Levels of sirolimus in saliva and blood following oral topical sustained-release varnish delivery system application

Cancer Chemotherapy and Pharmacology
Zakhar NudelmanRakefet Czerninski

Abstract

Sirolimus (rapamycin) is a mammalian target of rapamycin pathway blocker. The efficacy of sirolimus is currently studied for its antiproliferative properties in various malignancies and particularly in squamous cell carcinoma and other oral disorders. Topical application at the oral cavity can augment sirolimus availability at the site of action by increasing sirolimus levels in saliva and hence efficacy, along with improved safety (low levels in the blood to avoid side effects) and compliance. Our purpose was to evaluate the release profile and safety of a topical sirolimus sustained-release varnish drug delivery system. Sirolimus sustained-release varnish drug delivery system containing a total of 0.5 mg of the drug was applied to nine healthy male volunteers. Saliva and blood levels were determined utilizing mass spectrometry and chemiluminescent microparticle immunoassay, respectively. The prolonged release profile and safety were evaluated for the oral topical delivery system. After the application of the drug delivery system, a sustained-release profile was observed in the oral cavity. We have measured moderate sirolimus levels for up to 12 h. The safety was confirmed, and systemic sirolimus blood levels were negligible. ...Continue Reading

References

Apr 1, 1990·Pharmaceutical Research·M Friedman, D Steinberg
Mar 15, 2003·American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics·Nurit BeythDoron Steinberg
Dec 20, 2005·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Doron SteinbergMichael Friedman
May 19, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Scott M LippmanReuben Lotan
Oct 21, 2006·The Cochrane Database of Systematic Reviews·G LodiA Carrassi
Nov 11, 2008·Dermatology : International Journal for Clinical and Investigative Dermatology·A SoriaC Francès
May 1, 2009·Clinical Oral Investigations·Rakefet CzerninskiMichael Friedman
Jul 16, 2010·Experimental Dermatology·Melanie KremerBarbara S Schnierle
Jul 30, 2010·Clinical Chemistry and Laboratory Medicine : CCLM·Caroline CourtaisJean Paul Cristol
Sep 6, 2011·Oral Oncology·Marcio Augusto de OliveiraNathaniel S Treister
Jan 28, 2012·Current Treatment Options in Oncology·Shaun A NguyenTerry A Day
Sep 11, 2012·Cell Stem Cell·Ramiro Iglesias-BartolomeJ Silvio Gutkind
Feb 19, 2013·International Journal of Cancer. Journal International Du Cancer·Pinaki BoseJoseph C Dort
Feb 27, 2013·Indian Dermatology Online Journal·Bhushan Madke
Mar 6, 2013·Journal of Cellular Physiology·Anya Alayev, Marina K Holz
Jun 5, 2013·Neoplasia : an International Journal for Oncology Research·Joseph D CoppockJohn H Lee
Feb 1, 2014·Nature Reviews. Drug Discovery·David A Fruman, Christian Rommel
Feb 20, 2014·Oral Diseases·Z NudelmanR Czerninski
May 2, 2014·Frontiers in Oncology·Camillo PortaAlessandra Mosca

❮ Previous
Next ❯

Citations

Jan 2, 2016·Clinica Chimica Acta; International Journal of Clinical Chemistry·Adam J McShaneSihe Wang
Jul 28, 2016·Expert Opinion on Drug Delivery·Doron Steinberg, Michael Friedman
Jun 27, 2017·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Kashappa Goud H Desai
Sep 12, 2019·Bioanalysis·Lucía Paniagua-GonzálezAna de-Castro-Ríos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.